Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2019 / Article

Review Article | Open Access

Volume 2019 |Article ID 1318795 | https://doi.org/10.1155/2019/1318795

Xiaole Wang, Chuqiao Shen, Jie Zhu, Guoming Shen, Zegeng Li, Jingcheng Dong, "Long Noncoding RNAs in the Regulation of Oxidative Stress", Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 1318795, 7 pages, 2019. https://doi.org/10.1155/2019/1318795

Long Noncoding RNAs in the Regulation of Oxidative Stress

Academic Editor: Demetrios Kouretas
Received01 Nov 2018
Revised29 Nov 2018
Accepted18 Dec 2018
Published17 Feb 2019

Abstract

Oxidative stress takes responsibility for various diseases, such as chronic obstructive pulmonary disease (COPD), Alzheimer’s disease (AD), and cardiovascular disease; nevertheless, there is still a lack of specific biomarkers for the guidance of diagnosis and treatment of oxidative stress-related diseases. In recent years, growing studies have documented that oxidative stress has crucial correlations with long noncoding RNAs (lncRNAs), which have been identified as important transcriptions involving the process of oxidative stress, inflammation, etc. and been regarded as the potential specific biomarkers. In this paper, we review links between oxidative stress and lncRNAs, highlight lncRNAs that refer to oxidative stress, and conclude that lncRNAs have played a negative or positive role in the oxidation/antioxidant system, which may be helpful for the further investigation of specific biomarkers of oxidative stress-related diseases.

1. Introduction

Oxidative stress is described as the imbalance of the oxidation/antioxidant system caused by the accumulation of free radicals, primarily the reactive oxygen species (ROS) and the reactive nitrogen species (RNS), after the stimulation of endogenous and external environment [1]. Indisputably, oxidative stress could lead to cell death and the dysfunction of physiology, which could ascribe to DNA damage, inflammation, etc. [2, 3]. As oxidative stress has widely contributed to diverse diseases, including AD, COPD, and cardiovascular disease [46], specific biomarkers for the diagnosis and treatment of oxidative stress related-diseases are urgently needed. Studies have identified that oxidative stress is an important activator of some critical antioxidative pathways, whereas like Nrf2/Keap1/ARE [7] still cannot be effectively activated to eliminate free radicals to exert the protective roles. COPD, for example, has shown strengthening in oxidative stress and reduced in the expression of the Nrf2 protein as well as the antioxidant genes [8]; it is hinted that there are pivotal molecules intervened in modulating oxidative stress.

Over the past decades, advanced sequencing technologies have uncovered that approximately 2% of the genome is transcribed into messenger RNA (mRNA) and a myriad of lncRNAs are pervasively transcribed [9]. lncRNAs are characterized as transcripts with more than 200 nucleotides (nt) in length with low or no ability to encode for proteins [10]. It is appreciated that lncRNAs have relevance to DNA expression, RNA transportation, etc. through molecular interactions: RNA-protein, RNA-RNA, and so forth [11, 12]. Currently, a large portion of lncRNAs are functionally characterized; nevertheless, a limited number of annotated lncRNAs has enacted important roles in oxidative stress related-diseases like the nervous system disease, respiratory system disease, and cardiovascular system disease [1315]. Recent reports have also revealed that lncRNAs played a negative or positive role in response to oxidative stress [16, 17], which implicates that lncRNAs as key molecules may involve in the oxidative stress field. And the low conservation and tissue-specific features of most lncRNAs suggest that lncRNAs could enact specific biomarkers for oxidative stress related-diseases [18, 19].

In the paper, we review the cis and trans pattern of lncRNAs and the oxidation/antioxidant system. More importantly, we underline the current researches of lncRNAs that involved in the oxidation/antioxidant system and synthesize their potential molecular mechanisms in modulating the oxidative stress process for further investigation.

2. Oxidative Stress and Nrf2/Keap1/ARE Pathway

ROS and RNS have constructed the primary proportion of free radicals (FR), which are mainly derived from the accumulation of exogenous FR such as cigarette smoking and air pollution and endogenous FR primarily released from various inflammatory cells like neutrophil and macrophage [20]. Theoretically, the performance of oxidative stress is accompanied by the activation of antioxidant pathways. For instance, the nuclear factor erythroid 2-related factor 2/kelch-like ECH-associated protein 1/antioxidant response element (Nrf2/Keap1/ARE) pathway is automatically executed in response to oxidative stress to maintain the balance of the oxidation/antioxidant system. Under physiological condition, the Nrf2, a crucial antioxidant gene activator of the Nrf2/Keap1/ARE pathway, is restrained at a low level due to the combination of Keap1. With the stimulation of oxidative stress, Nrf2 detaches from Keap1, enters and accumulates in the nucleus, and combines with ARE; afterwards, a series of antioxidative protein genes including NAD(P)H quinone dehydrogenase 1 (NQO1), heme oxygenase 1 (HO-1), and glutathione (GSH) are transcribed to maintain the balance of oxidation/antioxidant [21] (see Figure 1). But unexpectedly, a shortage of antioxidative proteins have been found in numerous diseases; recent achievements of the correlations between lncRNAs and oxidative stress may provide a novel strategy for elucidating the phenomenon.

3. The Pattern of lncRNA in Targeting Genes

Currently, the criterion for the category of lncRNAs has not yet reached an agreement due to the unclear functions of numerous lncRNAs. To a consensus, lncRNAs have been classified as sense, antisense, intronic, long intergenic noncoding RNA (lincRNA), and bidirectional, according to the transcription locus [22] (see Figure 2). Besides, lncRNAs have also been categorized as signal, decoy, guide, and scaffold molecules, based on the annotated lncRNAs [23]. According to the pattern of lncRNAs regulating target genes, they are commonly identified as the cis and trans lncRNAs [24]. As the cis and trans patterns are expected to predict new and unexpected biology mechanisms of lncRNAs [25], we briefly introduce the concept of the cis pattern and trans pattern of lncRNAs with examples. The cis pattern refers to lncRNAs that regulate the adjacent protein-coding genes or chromatin status. For example, X chromosome inactivation-specific transcript (Xist), ~17 kb (in mice), ~19 kb (in human), is a lncRNA on the X chromosome, and Xist as the cis pattern lncRNAs plays a key role in X chromosome inactivation [26]. Versus the cis pattern, the trans, independent of positional relationship, refers to lncRNAs whose transcriptional locus is away from their functional locations. As an example, HOX antisense intergenic RNA (HOTAIR) is located in the human chromosome 12 with 2.2 kb in length; as a scaffold, the 5 domain and the 3 domain are combined with polycomb suppression complex 2 (PRC2) and LSD1/CoREST/REST complex, respectively, to reedit the chromosome state and regulate target genes [27].

4. lncRNAs Involving in the Oxidative Stress

Aberrant expression of lncRNAs has been observed in various diseases [28]. Heretofore, a growing number of reports have elucidated that lncRNAs have shown relevance with the oxidation/antioxidant system; most lncRNAs have been connected with the Nrf2/Keap1/ARE pathway or aimed to the miRNA to exert functions. Based on the current researches of lncRNAs in the oxidative stress field, the lncRNAs implicated with oxidative stress are listed in the table (see Table 1).


lncRNAFunctionsRelevant pathwaysReferences

MALAT1(1) Downregulating Keap1Nrf2/Keap1/ARE[29]
(2) Preemptively binding with Nrf2 to inhibit the expression of Nrf2-target genesNrf2/Keap1/ARE[30]
(3) Binding with SP1p38MAPK[32]
(4) Targeting miR-145 to enhance the expression of VEGF-A and ANGPT2[33]
H19(1) Antagonizing the premature senescence of CPC[35]
(2) Attenuating oxidative stress and inflammation in the diabetic mouse model[36]
(3) As a competing endogenous molecule to affect the invasion and migration ability of cholangiocarcinoma cells[37]
SCAL1Driven by Nrf2, and protecting airway epithelial cells from oxidative stressNrf2/Keap1/ARE[38]
NEAT1(1) Reversing the superoxide in LPS-treated rat mesangial cells[41]
(2) Figured as a neuroprotector in nerve injury caused by oxidative stress[42]
gadd7Induced by ROS, and low expression of gadd7 could significantly lower the ROS[45]
MACC1-AS1Promoting the proliferation of gastric cancer cells, inhibiting apoptosis, and regulating metabolismAMPK/Lin28[47]
ODRULContributing to the toxicity in erythroid cells induced by AgNPsNrf2/Keap1/ARE; PI4K-AKT/JNK[48]
LINC01619A “sponge” of miR-27a[49]
LINC00963Attenuating renal fibrosis and oxidative stress in chronic renal[51]
FOXD3-AS1A “sponge” of microRNA-150[53]
BDNF-ASInvolving in decreasing cell viability and increasing cell apoptosis induced via oxidative stress[55]

4.1. MALAT1

Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is a lincRNA with 7 kb in length. It is documented that MALAT1 plays a negative or positive role in response to oxidative stress. As an activator of the antioxidant pathway, the overexpression of MALAT1 was observed in hydrogen peroxide- (H2O2-) induced human umbilical vein endothelial cells (HUVECs). Mechanically, MALAT1 lowered the Keap1 level to activate and stabilize the Nrf2 protein, thereby the antioxidant capacity was enhanced to attenuate the oxidative stress damage, lipid peroxidation, and DNA damage in H2O2-induced HUVECs [29]. MALAT1 has also been speculated as a Nrf2 regulator, which binds to Nrf2 prior to the combination of Nrf2 and ARE [30]. The regulatory interventions of MALAT1 suggest that actions on the Nrf2/Keap1/ARE pathway might be an important strategy of lncRNAs in regulating oxidative stress. In addition, the p38MAPK pathway, which has been illustrated to modulate the apoptosis and oxidative stress [31], was activated when MALAT1 was upregulated in human lens epithelial cells and binds to SP1 [32]. In addition to the above discussion, it has been observed that MALAT1 could target microRNAs (miRNAs) to alter the oxidative stress. An example is that MALAT1 showed upregulated in the brain microvascular endothelial cells under the condition of oxygen-glucose deprivation (OGD), and cells were protected from oxidative and ischemic stress damage; MALAT1 might target miR-145 to enhance the expression of VEGF-A and ANGPT2 to implement function [33]. In general, MALAT1 has implicated in oxidative stress, and various functions of MALAT1 might be due to the tissue-specific feature of lncRNAs.

4.2. H19

H19, 2.3 kb in length, is a highly conserved lncRNAs. Knockdown of H19 performed sensitively to H2O2, which is a common oxidative stress activator; meanwhile, six Nrf2-induced genes were reduced [34]. H2O2 could both downregulate H19 and its derived miR-675 in the cardiac progenitor cells (CPC), and the influence could be offset by the treatment of melatonin. It was further confirmed that H19-derived miR-675 targeted the 3UTR of USP10 to downregulate p53 and p21 proteins [35]. As the MALAT1 which is mentioned above, H19 could also exert functions through miRNAs. Overexpression of H19 attenuated oxidative stress and inflammation in a diabetic mouse model, and H19 might execute the antioxidant function by targeting miR-657 to inhibit voltage-dependent anion channel 1 (VDAC1) [36]. In addition, H19, as a competing endogenous RNA, targeted IL-16 and CXCR4 to affect the invasion and migration ability of cholangiocarcinoma cells; it might enact an oxidative stress receptor for the activation of the antioxidant [37].

4.3. SCAL1

lncRNA SCAL1, also known as XLOC-004924 or LUCAT1, is a lincRNA located between the G protein-coupled receptor 98 (GPR98) and arrestin domain-containing 3 (ARRDC3) in human chromosome 5. SCAL1 is closely related to Nrf2, and knockdown experiments of SCAL1 or Nrf2 showed a significant increase of the toxicity of cigarette smoke (CS) in A549 cells. Meanwhile, the expression of SCAL1 was decreased, which blocked Nrf2 and further inhibited the cellular activity [38]; however, the recent studies also demonstrated that SCAL1 performed conversely functions in cancers [39, 40]. All results indicated that SCAL1 might perform a pivotal intermediate molecule in the process of Nrf2 regulating antioxidant molecules.

4.4. NEAT1

Nuclear-enriched abundant transcript 1 (NEAT1) is a highly conserved lincRNA. It was observed that NEAT1 could reverse the superoxide in LPS-treated rat mesangial cells [41]. NEAT1 increased the proliferation and metastasis of tumor cells and counteracted the H2O2-induced neuronal damage. The high expression of NEAT1 was also performed in enhancing the cell viability in neuro2A cells, which has showed oxidative stress and cell damage with the induction of H2O2; it suggests that NEAT1 could play as a neuroprotector in nerve injury caused by oxidative stress [42].

4.5. gadd7

Growth arrested DNA damage-inducible gene 7 (gadd7) is described as a contributor to DNA damage, lipotoxic stress, and nonlipid oxidative stress [43, 44]. It is the first lncRNA that presented in a feed-forward loop with oxidative stress and also enriched in ROS environments derived from lipotoxic stress. The silence of gadd7 could significantly lower ROS and delay and reduce ROS-induced endoplasmic reticulum stress [45]. Another example is that the dysregulation of gadd7 was observed in varicocele-related sperm damages [46]; as a result, gadd7 is speculated as an important participator in sperm damage caused by oxidative stress.

4.6. MACC1-AS1

MACC1-AS1 is transcribed from the antisense of MACC1, which is a gastric cancer metastasis-associated regulator. MACC1-AS1 has the ability to stabilize and enhance the expression of MACC1. High expression of MACC1-AS1 could promote the proliferation of gastric cancer cells, inhibit apoptosis, and regulate metabolism. Mechanistically, the AMPK/Lin28 pathway might coordinate with the process of MACC1-AS1 to enhance glycolysis and antioxidant capacity to modulate metabolic plasticity [47].

4.7. ODRUL

Osteosarcoma doxorubicin resistance-related upregulated lncRNA (ODRUL) has been elucidated to be induced by Nrf2 in erythroid cells treated with AgNPs. Although Nrf2 is a well-recognized antioxidant core molecule, it also shows cell damage under oxidative stress. Nrf2 promoted the transcription of ODRUL in K562 cells, thereby ODRUL interacted with PI4Kα protein to target AKT and JNK, negatively regulated Bcl2 levels, and eventually triggered cell death [48].

4.8. LINC01619

LINC01619 acts as a “sponge” lincRNA of miR-27a, which has been illustrated involving endoplasmic reticulum stress and podocyte injury in diabetic nephropathy. It is speculated that LINC01619, as a competitive endogenous RNA, triggered oxidative stress and regulated miR-27a/FOXO1 to the mediation of endoplasmic reticulum stress and podocyte injury [49].

4.9. LINC00963

LINC00963 was initially revealed to involve in prostate cancer [50]. Blocking LINC00963 weakened the cell apoptosis, and LINC00963 might enhance the expression of FoxO3 to attenuate renal fibrosis and oxidative stress in chronic renal failure. LINC00963 is a potential marker in indicating the progression and outcome of chronic renal failure [51].

4.10. lnc-CD1D-2:1

lnc-CD1D-2:1, a lincRNA with two exons, has changed synchronously with ROS and performed increasingly in melanocytes irradiated by ultraviolet radiation B (UVB). Besides, lnc-CD1D-2:1, which was induced following UVB irradiation, inhibited phosphorylation of p38, and it is implied that ROS involved in UVB irradiation to produce melanin may be attributed to lnc-CD1D-2:1 [52].

4.11. FOXD3-AS1

FOXD3-AS1 is transcribed from the antisense of FOXD3, and it could accelerate the apoptosis of lung epithelial cells treated by oxidative stress. It has been confirmed that microRNA-150 is a protector of lung epithelial cell injury; FOXD3-AS1, as a “sponge” or the endogenous competitor of microRNA-150, blocked the protective function of microRNA-150 and enhanced the apoptosis of lung epithelial cells induced by oxidative stress [53].

4.12. BDNF-AS

BDNF-AS, a nature antisense lncRNA of BDNF, has been documented as a negative regulator of BDNF [54]. The content of ROS and MDA went with the expression of BDNF-AS; inversely, the antioxidant proteins like superoxide dismutase and catalase were strikingly upregulated. Induced by oxidative stress, BDNF-AS performed in decreasing cell viability and increasing cell apoptosis [55].

5. Conclusions

In recent years, cumulative studies have elucidated that lncRNAs, which were originally regarded as “junk” and “noise,” have widely involved in cancer, immune response, etc. [56, 57] and associated with oxidative stress [17]. Theoretically, the antioxidant system is activated in response to oxidative stress; however, crucial protective regulators like Nrf2 have shown insufficient in COPD, Alzheimer’s disease, etc. [58]. Here, we highlight the lncRNAs associated with oxidative stress and present their potential mechanisms. In conclusion, lncRNAs could exert cytoprotective or damaging effects in intervening the Nrf2/Keap1/ARE antioxidant pathway, interacting with miRNA, etc. Dramatically, some lncRNAs have also performed opposite roles in different studies, which might be due to the tissue-specific feature of the lncRNAs. Our study suggests that these oxidative stress-related lncRNAs, as potential pivotal biomarkers and medicine targets, may provide a novel strategy for the diagnosis and treatment of diseases. Future studies will contribute to the precise mechanism of lncRNAs in the regulation of oxidative stress.

Disclosure

Xiaole Wang and Chuqiao Shen are considered the co-first authors.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Authors’ Contributions

Xiaole Wang and Chuqiao Shen contributed equally to this work.

Acknowledgments

This study is supported by the University Natural Science Research Project of Anhui Province (grant number KJ2018A0277), the National Natural Science Foundation of China (grant number 81403308), and Exploratory Research Foundation of Anhui University of Chinese Medicine (grant number 2017HXTS54). We thank Key Laboratory for Basics of Integration of Traditional Chinese and Western Medicine in Anhui Province for the supports.

References

  1. Z. Durackova, “Some current insights into oxidative stress,” Physiological Research, vol. 59, no. 4, pp. 459–469, 2010. View at: Google Scholar
  2. P. Moller and S. Loft, “Oxidative damage to DNA and lipids as biomarkers of exposure to air pollution,” Environmental Health Perspectives, vol. 118, no. 8, pp. 1126–1136, 2010. View at: Publisher Site | Google Scholar
  3. M. Mittal, M. R. Siddiqui, K. Tran, S. P. Reddy, and A. B. Malik, “Reactive oxygen species in inflammation and tissue injury,” Antioxidants & Redox Signaling, vol. 20, no. 7, pp. 1126–1167, 2014. View at: Publisher Site | Google Scholar
  4. W. Ahmad, B. Ijaz, K. Shabbiri, F. Ahmed, and S. Rehman, “Oxidative toxicity in diabetes and Alzheimer’s disease: mechanisms behind ROS/RNS generation,” Journal of Biomedical Science, vol. 24, no. 1, p. 76, 2017. View at: Publisher Site | Google Scholar
  5. P. A. Kirkham and P. J. Barnes, “Oxidative stress in COPD,” Chest, vol. 144, no. 1, pp. 266–273, 2013. View at: Publisher Site | Google Scholar
  6. G. Csányi and F. J. Miller Jr., “Oxidative stress in cardiovascular disease,” International Journal of Molecular Sciences, vol. 15, no. 4, pp. 6002–6008, 2014. View at: Publisher Site | Google Scholar
  7. B. M. Hybertson, B. Gao, S. K. Bose, and J. M. McCord, “Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation,” Molecular Aspects of Medicine, vol. 32, no. 4-6, pp. 234–246, 2011. View at: Publisher Site | Google Scholar
  8. D. Malhotra, R. Thimmulappa, N. Vij et al., “Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 12, pp. 1196–1207, 2009. View at: Publisher Site | Google Scholar
  9. S. Djebali, C. A. Davis, A. Merkel et al., “Landscape of transcription in human cells,” Nature, vol. 489, no. 7414, pp. 101–108, 2012. View at: Publisher Site | Google Scholar
  10. The FANTOM Consortium and the RIKEN Genome Exploration Research Group Phase I & II Team, “Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs,” Nature, vol. 420, no. 6915, pp. 563–573, 2002. View at: Publisher Site | Google Scholar
  11. Y. Tay, J. Rinn, and P. P. Pandolfi, “The multilayered complexity of ceRNA crosstalk and competition,” Nature, vol. 505, no. 7483, pp. 344–352, 2014. View at: Publisher Site | Google Scholar
  12. V. A. Moran, R. J. Perera, and A. M. Khalil, “Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs,” Nucleic Acids Research, vol. 40, no. 14, pp. 6391–6400, 2012. View at: Publisher Site | Google Scholar
  13. R. E. Andersen and D. A. Lim, “Forging our understanding of lncRNAs in the brain,” Cell and Tissue Research, vol. 371, no. 1, pp. 55–71, 2018. View at: Publisher Site | Google Scholar
  14. J. Zhang, Y. Zhu, and R. Wang, “Long noncoding RNAs in respiratory diseases,” Histology and Histopathology, vol. 33, no. 8, pp. 747–756, 2018. View at: Publisher Site | Google Scholar
  15. C. Bar, S. Chatterjee, and T. Thum, “Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy,” Circulation, vol. 134, no. 19, pp. 1484–1499, 2016. View at: Publisher Site | Google Scholar
  16. P. Fuschi, M. Carrara, C. Voellenkle et al., “Central role of the p53 pathway in the noncoding-RNA response to oxidative stress,” Aging, vol. 9, no. 12, pp. 2559–2586, 2017. View at: Publisher Site | Google Scholar
  17. C. Kim, D. Kang, E. K. Lee, and J. S. Lee, “Long noncoding RNAs and RNA-binding proteins in oxidative stress, cellular senescence, and age-related diseases,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 2062384, 21 pages, 2017. View at: Publisher Site | Google Scholar
  18. P. Carninci, T. Kasukawa, S. Katayama et al., “The transcriptional landscape of the mammalian genome,” Science, vol. 309, no. 5740, pp. 1559–1563, 2005. View at: Publisher Site | Google Scholar
  19. T. Ravasi, H. Suzuki, K. C. Pang et al., “Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome,” Genome Research, vol. 16, no. 1, pp. 11–19, 2006. View at: Publisher Site | Google Scholar
  20. T. Finkel and N. J. Holbrook, “Oxidants, oxidative stress and the biology of ageing,” Nature, vol. 408, no. 6809, pp. 239–247, 2000. View at: Publisher Site | Google Scholar
  21. P. Canning, F. J. Sorrell, and A. N. Bullock, “Structural basis of Keap1 interactions with Nrf2,” Free Radical Biology & Medicine, vol. 88, Part B, pp. 101–107, 2015. View at: Publisher Site | Google Scholar
  22. C. P. Ponting, P. L. Oliver, and W. Reik, “Evolution and functions of long noncoding RNAs,” Cell, vol. 136, no. 4, pp. 629–641, 2009. View at: Publisher Site | Google Scholar
  23. K. C. Wang and H. Y. Chang, “Molecular mechanisms of long noncoding RNAs,” Molecular Cell, vol. 43, no. 6, pp. 904–914, 2011. View at: Publisher Site | Google Scholar
  24. F. Kopp and J. T. Mendell, “Functional classification and experimental dissection of long noncoding RNAs,” Cell, vol. 172, no. 3, pp. 393–407, 2018. View at: Publisher Site | Google Scholar
  25. A. E. Kornienko, P. M. Guenzl, D. P. Barlow, and F. M. Pauler, “Gene regulation by the act of long non-coding RNA transcription,” BMC Biology, vol. 11, no. 1, p. 59, 2013. View at: Publisher Site | Google Scholar
  26. A. Cerase, G. Pintacuda, A. Tattermusch, and P. Avner, “Xist localization and function: new insights from multiple levels,” Genome Biology, vol. 16, no. 1, p. 166, 2015. View at: Publisher Site | Google Scholar
  27. M. C. Tsai, O. Manor, Y. Wan et al., “Long noncoding RNA as modular scaffold of histone modification complexes,” Science, vol. 329, no. 5992, pp. 689–693, 2010. View at: Publisher Site | Google Scholar
  28. L. W. Harries, “Long non-coding RNAs and human disease,” Biochemical Society Transactions, vol. 40, no. 4, pp. 902–906, 2012. View at: Publisher Site | Google Scholar
  29. R. Zeng, R. Zhang, X. Song et al., “The long non-coding RNA MALAT1 activates Nrf2 signaling to protect human umbilical vein endothelial cells from hydrogen peroxide,” Biochemical and Biophysical Research Communications, vol. 495, no. 4, pp. 2532–2538, 2018. View at: Publisher Site | Google Scholar
  30. J. Chen, S. Ke, L. Zhong et al., “Long noncoding RNA MALAT1 regulates generation of reactive oxygen species and the insulin responses in male mice,” Biochemical Pharmacology, vol. 152, pp. 94–103, 2018. View at: Publisher Site | Google Scholar
  31. E. Boilan, V. Winant, E. Dumortier et al., “Role of p38MAPK and oxidative stress in copper-induced senescence,” Age, vol. 35, no. 6, pp. 2255–2271, 2013. View at: Publisher Site | Google Scholar
  32. W. Gong, G. Zhu, J. Li, and X. Yang, “LncRNA MALAT1 promotes the apoptosis and oxidative stress of human lens epithelial cells via p38MAPK pathway in diabetic cataract,” Diabetes Research and Clinical Practice, vol. 144, pp. 314–321, 2018. View at: Publisher Site | Google Scholar
  33. L. Ren, C. Wei, K. Li, and Z. Lu, “LncRNA MALAT1up-regulates VEGF-A and ANGPT2 to promote angiogenesis in brain microvascular endothelial cells against oxygen-glucose deprivation via targeting miR-145,” Bioscience Reports, no. article BSR20180226, 2018. View at: Publisher Site | Google Scholar
  34. Z. G. Zheng, H. Xu, S. S. Suo et al., “The essential role of H19 contributing to cisplatin resistance by regulating glutathione metabolism in high-grade serous ovarian cancer,” Scientific Reports, vol. 6, no. 1, article 26093, 2016. View at: Publisher Site | Google Scholar
  35. B. Cai, W. Ma, C. Bi et al., “Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit+ cardiac progenitor cells by promoting miR-675,” Journal of Pineal Research, vol. 61, no. 1, pp. 82–95, 2016. View at: Publisher Site | Google Scholar
  36. H. J. Sun, B. Hou, X. Wang, X. X. Zhu, K. X. Li, and L. Y. Qiu, “Endothelial dysfunction and cardiometabolic diseases: role of long non-coding RNAs,” Life Sciences, vol. 167, pp. 6–11, 2016. View at: Publisher Site | Google Scholar
  37. W. T. Wang, H. Ye, P. P. Wei et al., “LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner,” Journal of Hematology & Oncology, vol. 9, no. 1, p. 117, 2016. View at: Publisher Site | Google Scholar
  38. P. Thai, S. Statt, C. H. Chen, E. Liang, C. Campbell, and R. Wu, “Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines,” American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 2, pp. 204–211, 2013. View at: Publisher Site | Google Scholar
  39. Z. Zheng, F. Zhao, D. Zhu et al., “Long non-coding RNA LUCAT1 promotes proliferation and invasion in clear cell renal cell carcinoma through AKT/GSK-3β signaling pathway,” Cellular Physiology and Biochemistry, vol. 48, no. 3, pp. 891–904, 2018. View at: Publisher Site | Google Scholar
  40. H. Yu, Y. Xu, D. Zhang, and G. Liu, “Long noncoding RNA LUCAT1 promotes malignancy of ovarian cancer through regulation of miR-612/HOXA13 pathway,” Biochemical and Biophysical Research Communications, vol. 503, no. 3, pp. 2095–2100, 2018. View at: Publisher Site | Google Scholar
  41. Y. Chen, J. Qiu, B. Chen et al., “Long non-coding RNA NEAT1 plays an important role in sepsis-induced acute kidney injury by targeting miR-204 and modulating the NF-κB pathway,” International Immunopharmacology, vol. 59, pp. 252–260, 2018. View at: Publisher Site | Google Scholar
  42. J. S. Sunwoo, S. T. Lee, W. Im et al., “Altered expression of the long noncoding RNA NEAT1 in Huntington’s disease,” Molecular Neurobiology, vol. 54, no. 2, pp. 1577–1586, 2017. View at: Publisher Site | Google Scholar
  43. M. C. Hollander, I. Alamo, and A. J. Fornace Jr., “A novel DNA damage-inducible transcript, gadd7, inhibits cell growth, but lacks a protein product,” Nucleic Acids Research, vol. 24, no. 9, pp. 1589–1593, 1996. View at: Publisher Site | Google Scholar
  44. D. R. Crawford, G. P. Schools, S. L. Salmon, and K. J. A. Davies, “Hydrogen peroxide induces the expression of adapt15, a novel RNA associated with polysomes in hamster HA-1 cells,” Archives of Biochemistry and Biophysics, vol. 325, no. 2, pp. 256–264, 1996. View at: Publisher Site | Google Scholar
  45. R. T. Brookheart, C. I. Michel, L. L. Listenberger, D. S. Ory, and J. E. Schaffer, “The non-coding RNA gadd7 is a regulator of lipid-induced oxidative and endoplasmic reticulum stress,” Journal of Biological Chemistry, vol. 284, no. 12, pp. 7446–7454, 2009. View at: Publisher Site | Google Scholar
  46. J. Zhao, H. Li, H. Deng et al., “LncRNA gadd7, increased in varicocele patients, suppresses cell proliferation and promotes cell apoptosis,” Oncotarget, vol. 9, no. 4, pp. 5105–5110, 2018. View at: Publisher Site | Google Scholar
  47. Y. Zhao, Y. Liu, L. Lin et al., “The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1,” Molecular Cancer, vol. 17, no. 1, p. 69, 2018. View at: Publisher Site | Google Scholar
  48. M. Gao, B. Zhao, M. Chen et al., “Nrf-2-driven long noncoding RNA ODRUL contributes to modulating silver nanoparticle-induced effects on erythroid cells,” Biomaterials, vol. 130, pp. 14–27, 2017. View at: Publisher Site | Google Scholar
  49. X. Bai, J. Geng, X. Li et al., “Long noncoding RNA LINC01619 regulates microRNA-27a/forkhead box protein O1 and endoplasmic reticulum stress-mediated podocyte injury in diabetic nephropathy,” Antioxidants & Redox Signaling, vol. 29, no. 4, pp. 355–376, 2018. View at: Publisher Site | Google Scholar
  50. L. Wang, S. Han, G. Jin et al., “Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence,” International Journal of Oncology, vol. 44, no. 6, pp. 2041–2049, 2014. View at: Publisher Site | Google Scholar
  51. W. Chen, L. Zhang, Z. Q. Zhou et al., “Effects of long non-coding RNA LINC00963 on renal interstitial fibrosis and oxidative stress of rats with chronic renal failure via the Foxo signaling pathway,” Cellular Physiology and Biochemistry, vol. 46, no. 2, pp. 815–828, 2018. View at: Publisher Site | Google Scholar
  52. Q. Zeng, Q. Wang, X. Chen et al., “Analysis of lncRNAs expression in UVB-induced stress responses of melanocytes,” Journal of Dermatological Science, vol. 81, no. 1, pp. 53–60, 2016. View at: Publisher Site | Google Scholar
  53. D. Zhang, H. Lee, J. A. Haspel, and Y. Jin, “Long noncoding RNA FOXD3-AS1 regulates oxidative stress-induced apoptosis via sponging microRNA-150,” The FASEB Journal, vol. 31, no. 10, pp. 4472–4481, 2017. View at: Publisher Site | Google Scholar
  54. F. Modarresi, M. A. Faghihi, M. A. Lopez-Toledano et al., “Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation,” Nature Biotechnology, vol. 30, no. 5, pp. 453–459, 2012. View at: Publisher Site | Google Scholar
  55. C. C. Guo, C. H. Jiao, and Z. M. Gao, “Silencing of LncRNA BDNF-AS attenuates Aβ25-35-induced neurotoxicity in PC12 cells by suppressing cell apoptosis and oxidative stress,” Neurological Research, vol. 40, no. 9, pp. 795–804, 2018. View at: Publisher Site | Google Scholar
  56. L. Zhang, D. Peng, A. K. Sood, C. V. Dang, and X. Zhong, “Shedding light on the dark cancer genomes: long noncoding RNAs as novel biomarkers and potential therapeutic targets for cancer,” Molecular Cancer Therapeutics, vol. 17, no. 9, pp. 1816–1823, 2018. View at: Publisher Site | Google Scholar
  57. M. K. Atianand, D. R. Caffrey, and K. A. Fitzgerald, “Immunobiology of long noncoding RNAs,” Annual Review of Immunology, vol. 35, no. 1, pp. 177–198, 2017. View at: Publisher Site | Google Scholar
  58. C. P. Ramsey, C. A. Glass, M. B. Montgomery et al., “Expression of Nrf2 in neurodegenerative diseases,” Journal of Neuropathology and Experimental Neurology, vol. 66, no. 1, pp. 75–85, 2007. View at: Publisher Site | Google Scholar

Copyright © 2019 Xiaole Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views1753
Downloads727
Citations

Related articles